{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:48:02Z","timestamp":1782200882112,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s11655-026-3957-7","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:46:18Z","timestamp":1775043978000},"page":"623-630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Shenling Baizhu Powder Alleviated Lung Damage and Enhanced Immunoregulatory Activity in Mice with Non-Tuberculosis Mycobacterial Lung Disease"],"prefix":"10.1007","volume":"32","author":[{"given":"Li-bo","family":"Zhen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-qing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-min","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"3957_CR1","doi-asserted-by":"publisher","first-page":"1321273","DOI":"10.3389\/fmicb.2024.1321273","volume":"15","author":"N Narimisa","year":"2024","unstructured":"Narimisa N, Bostanghadiri N, Goodarzi F, Razavi S, Jazi FM. Prevalence of Mycobacterium kansasii in clinical and environmental isolates, a systematic review and metaanalysis. Front Microbiol 2024;15:1321273.","journal-title":"Front Microbiol"},{"key":"3957_CR2","doi-asserted-by":"publisher","first-page":"e0147521","DOI":"10.1128\/spectrum.01475-21","volume":"10","author":"Y Guo","year":"2022","unstructured":"Guo Y, Cao Y, Liu H, Yang J, Wang W, Wang B, et al. Clinical and microbiological characteristics of Mycobacterium kansasii pulmonary infections in China. Microbiol Spectr 2022;10:e0147521.","journal-title":"Microbiol Spectr"},{"key":"3957_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fimmu.2020.00303","volume":"11","author":"CN Ratnatunga","year":"2020","unstructured":"Ratnatunga CN, Lutzky VP, Kupz A, Doolan DL, Reid DW, Field M, et al. The rise of non-tuberculosis mycobacterial lung disease. Front Immunol 2020;11:303.","journal-title":"Front Immunol"},{"key":"3957_CR4","doi-asserted-by":"publisher","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","volume":"56","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr., Andrejak C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Eur Respir J 2020;56:2000535.","journal-title":"Eur Respir J"},{"key":"3957_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1055\/s-0038-1660473","volume":"39","author":"D Basille","year":"2018","unstructured":"Basille D, Jounieaux V, Andr\u00e9jak C. Treatment of other nontuberculous mycobacteria. Semin Respir Crit Care Med 2018;39:377\u2013382.","journal-title":"Semin Respir Crit Care Med"},{"key":"3957_CR6","doi-asserted-by":"publisher","first-page":"110268","DOI":"10.1016\/j.vetimm.2021.110268","volume":"237","author":"JR Stabel","year":"2021","unstructured":"Stabel JR, Waters WR, Bannantine JP, Palmer MV. Comparative cellular immune responses in calves after infection with Mycobacterium avium subsp paratuberculosis, M. avium subsp avium, M. kansasii and M. bovis. Vet Immunol Immunopathol 2021;237:110268.","journal-title":"Vet Immunol Immunopathol"},{"key":"3957_CR7","doi-asserted-by":"publisher","first-page":"e0081924","DOI":"10.1128\/spectrum.00819-24","volume":"12","author":"H Kim","year":"2024","unstructured":"Kim H, Shin S. Immunogenicity and vaccine potential of clinical isolate Mycobacterium kansasii strain against Mycobacterium tuberculosis infection. Microbiol Spectr 2024;12:e0081924.","journal-title":"Microbiol Spectr"},{"key":"3957_CR8","doi-asserted-by":"publisher","first-page":"113683","DOI":"10.1016\/j.biopha.2022.113683","volume":"155","author":"H Ding","year":"2022","unstructured":"Ding H, Wang G, Yu Z, Sun H, Wang L. Role of interferon-gamma (IFN-\u03b3) and IFN-\u03b3 receptor 1\/2 (IFN \u03b3 R1\/2) in regulation of immunity, infection, and cancer development: IFN-\u03b3-dependent or independent pathway. Biomed Pharmacother 2022;155:113683.","journal-title":"Biomed Pharmacother"},{"key":"3957_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/microorganisms12010230","volume":"12","author":"A Vojdani","year":"2024","unstructured":"Vojdani A, Koksoy S, Vojdani E, Engelman M, Benzvi C, Lerner A. Natural killer cells and cytotoxic T cells: complementary partners against microorganisms and cancer. Microorganisms 2024;12:230.","journal-title":"Microorganisms"},{"key":"3957_CR10","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.4049\/jimmunol.1800123","volume":"201","author":"HC Lai","year":"2018","unstructured":"Lai HC, Chang CJ, Lin CS, Wu TR, Hsu YJ, Wu TS, et al. NK cell-derived IFN-\u03b3 protects against nontuberculous mycobacterial lung infection. J Immunol 2018;201:1478\u20131490.","journal-title":"J Immunol"},{"key":"3957_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Su Y, Jiao A, Wang X, Zhang B. T cells in health and disease. Signal Transduct Target Ther 2023;8:235.","journal-title":"Signal Transduct Target Ther"},{"key":"3957_CR12","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/jpen.1505","volume":"43","author":"CS Lei","year":"2019","unstructured":"Lei CS, Wu JM, Lee PC, Kuo TC, Chen PD, Hou YC, et al. Antecedent administration of glutamine benefits the homeostasis of CD4+ T cells and attenuates lung injury in mice with gut-derived polymicrobial sepsis. JPEN J Parenter Enter Nutr 2019;43:927\u2013936.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"3957_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","volume":"34","author":"CG Vinuesa","year":"2016","unstructured":"Vinuesa CG, Linterman MA, Yu D, MacLennan IC. Follicular helper T cells. Annu Rev Immunol 2016;34:335\u2013368.","journal-title":"Annu Rev Immunol"},{"key":"3957_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2018.06.011","volume":"74","author":"M Jean Bosco","year":"2018","unstructured":"Jean Bosco M, Wei M, Hou H, Yu J, Lin Q, Luo Y, et al. The exhausted CD4+CXCR5+ T cells involve the pathogenesis of human tuberculosis disease. Int J Infect Dis 2018;74:1\u20139.","journal-title":"Int J Infect Dis"},{"key":"3957_CR15","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s11655-023-3605-4","volume":"30","author":"Q Wang","year":"2024","unstructured":"Wang Q, Cheng M, Ban C, Zhang L, Wang H, Yang B, et al. Integrated Chinese and Western medicine in treatment of bronchopleural fistula with Mycobacterium abscessus: a case report. Chin J Integr Med 2024;30:742\u2013746.","journal-title":"Chin J Integr Med"},{"key":"3957_CR16","first-page":"17","volume":"43","author":"H Zhang","year":"2020","unstructured":"Zhang H, Hu Y, Liu G, Deng G, Li G. Clinical characteristics and traditional Chinese medicine syndrome analysis of non-tuberculosis mycobacterial lung disease. Guangxi J Tradit Chin Med (Chin) 2020;43:17\u201320.","journal-title":"Guangxi J Tradit Chin Med (Chin)"},{"key":"3957_CR17","first-page":"673","volume":"32","author":"Y Chen","year":"2022","unstructured":"Chen Y, Qiu G, Yin L. YIN Liang-sheng\u2019s experience in treating non-tuberculosis mycobacterial lung disease. Zhejiang J Integr Tradit Chin West Med (Chin) 2022;32:673\u2013675.","journal-title":"Zhejiang J Integr Tradit Chin West Med (Chin)"},{"key":"3957_CR18","first-page":"118","volume":"10","author":"X Pan","year":"2025","unstructured":"Pan X, Tang J, Wang J. Clinical effect of Modified Shenling Baizhu Powder combined with chemotherapy in the treatment of advanced driver gene negative non-small cell lung cancer of the lung and spleen deficiency type. Clin Res Pract (Chin) 2025;10:118\u2013122.","journal-title":"Clin Res Pract (Chin)"},{"key":"3957_CR19","volume-title":"Meta-analysis of Shenling Baizhu Powder in the treatment of bronchial asthma and chronic obstructive pulmonary disease","author":"M Liu","year":"2023","unstructured":"Liu M. Meta-analysis of Shenling Baizhu Powder in the treatment of bronchial asthma and chronic obstructive pulmonary disease [Dissertation]. Nanchong: North Sichuan Medical College;2023."},{"key":"3957_CR20","first-page":"146","volume":"33","author":"XH Li","year":"2025","unstructured":"Li XH, Zhao ZR, Luo JJ, Li YF. Effect of Shenling Baizhu Powder on immune function after partial lobectomy in Lewis lung cancer mice. Clin Res (Chin) 2025;33:146\u2013150.","journal-title":"Clin Res (Chin)"},{"key":"3957_CR21","first-page":"75","volume":"26","author":"D Li","year":"2020","unstructured":"Li D, Zhang X. Clinical efficacy of Modified Shenling Baizhu Powder on stroke-associated pneumonia with lungqi deficiency syndrome. Chin J Exp Tradit Med Formulae (Chin) 2020;26:75\u201380.","journal-title":"Chin J Exp Tradit Med Formulae (Chin)"},{"key":"3957_CR22","doi-asserted-by":"publisher","first-page":"1147067","DOI":"10.3389\/fmicb.2023.1147067","volume":"14","author":"Z Yao","year":"2023","unstructured":"Yao Z, Guo J, Du B, Hong L, Zhu Y, Feng X, et al. Effects of Shenling Baizhu Powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice. Front Microbiol 2023;14:1147067.","journal-title":"Front Microbiol"},{"key":"3957_CR23","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.3389\/fmicb.2018.02271","volume":"9","author":"MS DeStefano","year":"2018","unstructured":"DeStefano MS, Shoen CM, Cynamon MH. Therapy for Mycobacterium kansasii infection: beyond 2018. Front Microbiol 2018;9:2271.","journal-title":"Front Microbiol"},{"key":"3957_CR24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10875-022-01423-1","volume":"43","author":"WI Lee","year":"2023","unstructured":"Lee WI, Fang YF, Huang JL, You HL, Hsieh MY, Huang WT, et al. Distinct lymphocyte immunophenotyping and quantitative anti-interferon gamma autoantibodies in Taiwanese HIV-negative patients with non-tuberculous mycobacterial infections. J Clin Immunol 2023;43:717\u2013727.","journal-title":"J Clin Immunol"},{"key":"3957_CR25","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.4049\/jimmunol.2300460","volume":"211","author":"J Wang","year":"2023","unstructured":"Wang J, Zhang ZQ, Gigliotti F, Wright TW. IFN-\u03b3 limits immunopathogenesis but delays fungal clearance during pneumocystis pneumonia. J Immunol 2023;211:1397\u20131405.","journal-title":"J Immunol"},{"key":"3957_CR26","doi-asserted-by":"publisher","first-page":"eadk2693","DOI":"10.1126\/sciadv.adk2693","volume":"10","author":"AN Hegazy","year":"2024","unstructured":"Hegazy AN, Peine C, Niesen D, Panse I, Vainshtein Y, Kommer C, et al. Plasticity and lineage commitment of individual TH1 cells are determined by stable T-bet expression quantities. Sci Adv 2024;10:eadk2693.","journal-title":"Sci Adv"},{"key":"3957_CR27","doi-asserted-by":"publisher","first-page":"ofz484","DOI":"10.1093\/ofid\/ofz484","volume":"6","author":"UI Wu","year":"2019","unstructured":"Wu UI, Olivier KN, Kuhns DB, Fink DL, Sampaio EP, Zelazny AM, et al. Patients with idiopathic pulmonary nontuberculous mycobacterial disease have normal Th1\/Th2 cytokine responses but diminished Th17 cytokine and enhanced granulocyte-macrophage colony-stimulating factor production. Open Forum Infect Dis 2019;6:ofz484.","journal-title":"Open Forum Infect Dis"},{"key":"3957_CR28","first-page":"1157","volume":"36","author":"R Xu","year":"2016","unstructured":"Xu R, Guo QQ, Yang LP, Lai ML, Tong L. Variations of peripheral blood autoantibody, immunoglobuliln, and complement levels in patients with non-lactational mastitis and their clinical significances. J Southern Med Univ (Chin) 2016;36:1157\u20131159.","journal-title":"J Southern Med Univ (Chin)"},{"key":"3957_CR29","doi-asserted-by":"publisher","first-page":"e0311022","DOI":"10.1128\/spectrum.03110-22","volume":"10","author":"BG Jung","year":"2022","unstructured":"Jung BG, Dean K, Wadle C, Samten B, Tripathi D, Wallace RJ Jr., et al. Decreased interleukin-1 family cytokine production in patients with nontuberculous mycobacterial lung disease. Microbiol Spectr 2022;10:e0311022.","journal-title":"Microbiol Spectr"},{"key":"3957_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/ijmy.ijmy_212_19","volume":"9","author":"ZH Tavassol","year":"2020","unstructured":"Tavassol ZH, Aziziraftar SK, Behrouzi A, Ghazanfari M, Masoumi M, Fateh A, et al. Evaluation of Mycobacterium kansasii extracellular vesicles role in BALB\/c mice immune modulatory. Int J Mycobacteriol 2020;9:58\u201361.","journal-title":"Int J Mycobacteriol"},{"key":"3957_CR31","doi-asserted-by":"publisher","first-page":"e13755","DOI":"10.1590\/1414-431x2024e13755","volume":"57","author":"S Zhao","year":"2024","unstructured":"Zhao S, Zhang ZQ, Xu J, Zhou Z, Wu YH, Wu YH, et al. Plasma cytokine levels as markers of pathogenesis and treatment response in patients with non-tuberculous mycobacterial pulmonary disease. Braz J Med Biol Res 2024;57:e13755.","journal-title":"Braz J Med Biol Res"},{"key":"3957_CR32","first-page":"2","volume":"19","author":"H Sun","year":"2022","unstructured":"Sun H, Liu J, Feng R, Wang C, Li Y, Wang X. Follicular helper T cells in pulmonary tuberculosis: a retrospective study. Iran J Immunol 2022;19:2.","journal-title":"Iran J Immunol"},{"key":"3957_CR33","doi-asserted-by":"publisher","first-page":"111064","DOI":"10.1016\/j.intimp.2023.111064","volume":"124","author":"Q Liu","year":"2023","unstructured":"Liu Q, Pan X, An H, Du J, Li X, Sun W, et al. Building a model for the differential diagnosis of non-tuberculous mycobacterial lung disease and pulmonary tuberculosis: a case-control study based on immunological and radiological features. Int Immunopharmacol 2023;124:111064.","journal-title":"Int Immunopharmacol"},{"key":"3957_CR34","doi-asserted-by":"publisher","first-page":"154786","DOI":"10.1016\/j.phymed.2023.154786","volume":"114","author":"H Wang","year":"2023","unstructured":"Wang H, Jia X, Zhang M, Cheng C, Liang X, Wang X, et al. Isoliquiritigenin inhibits virus replication and virus-mediated inflammation via NRF2 signaling. Phytomedicine 2023;114:154786.","journal-title":"Phytomedicine"},{"key":"3957_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10753-021-01542-8","volume":"45","author":"Y Chen","year":"2022","unstructured":"Chen Y, Qu L, Li Y, Chen C, He W, Shen L, et al. Glycyrrhizic acid alleviates lipopolysaccharide (LPS)-induced acute lung injury by regulating angiotensin-converting enzyme-2 (ACE2) and Caveolin-1 signaling pathway. Inflammation 2022;45:253\u2013266.","journal-title":"Inflammation"},{"key":"3957_CR36","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3892\/or.2020.7891","volume":"45","author":"A Zeng","year":"2021","unstructured":"Zeng A, Liang X, Zhu S, Liu C, Wang S, Zhang Q, et al. Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF \u03baB signaling pathway. Oncol Rep 2021;45:717\u2013727.","journal-title":"Oncol Rep"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-3957-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-026-3957-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-3957-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:04:42Z","timestamp":1782198282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-026-3957-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3957"],"URL":"https:\/\/doi.org\/10.1007\/s11655-026-3957-7","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"5 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}